PubMed:21147760
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 195-206 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
| T2 | 337-343 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
| T3 | 497-503 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 195-206 | Glycan_Motif | denotes | sialic acid | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
| T2 | 337-343 | Glycan_Motif | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
| T3 | 497-503 | Glycan_Motif | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 195-206 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | sialic acid |
| T2 | 337-343 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
| T3 | 497-503 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 176-181 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
| T2 | 835-840 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
| T3 | 1181-1186 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 337-343 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T2 | 497-503 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 106-113 | gene:6480 | denotes | ST6GAL1 |
| T1 | 135-160 | disease:C2239176 | denotes | hepatocellular carcinomas |
| T2 | 118-125 | gene:10402 | denotes | ST3GAL6 |
| T3 | 135-160 | disease:C2239176 | denotes | hepatocellular carcinomas |
| T4 | 606-613 | gene:6480 | denotes | ST6GAL1 |
| T5 | 716-719 | disease:C2239176 | denotes | HCC |
| T6 | 606-613 | gene:6480 | denotes | ST6GAL1 |
| T7 | 690-714 | disease:C2239176 | denotes | hepatocellular carcinoma |
| T8 | 639-658 | gene:6487 | denotes | sialyltransferase 6 |
| T9 | 690-714 | disease:C2239176 | denotes | hepatocellular carcinoma |
| T10 | 660-667 | gene:10402 | denotes | ST3GAL6 |
| T11 | 690-714 | disease:C2239176 | denotes | hepatocellular carcinoma |
| T12 | 660-667 | gene:10402 | denotes | ST3GAL6 |
| T13 | 716-719 | disease:C2239176 | denotes | HCC |
| R1 | T0 | T1 | associated_with | ST6GAL1,hepatocellular carcinomas |
| R2 | T2 | T3 | associated_with | ST3GAL6,hepatocellular carcinomas |
| R3 | T4 | T5 | associated_with | ST6GAL1,HCC |
| R4 | T6 | T7 | associated_with | ST6GAL1,hepatocellular carcinoma |
| R5 | T8 | T9 | associated_with | sialyltransferase 6,hepatocellular carcinoma |
| R6 | T10 | T11 | associated_with | ST3GAL6,hepatocellular carcinoma |
| R7 | T12 | T13 | associated_with | ST3GAL6,HCC |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 690-714 | HP_0001402 | denotes | hepatocellular carcinoma |
| T2 | 1071-1076 | HP_0002664 | denotes | tumor |
| T3 | 1472-1480 | HP_0002664 | denotes | tumorous |
| T4 | 1658-1667 | HP_0002664 | denotes | cancerous |
| T5 | 1872-1877 | HP_0002664 | denotes | tumor |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 36-47 | FMAID:82816 | denotes | ganglioside |
| _T2 | 36-47 | FMAID:196811 | denotes | ganglioside |
| _T3 | 176-181 | FMAID:93672 | denotes | liver |
| _T4 | 176-181 | FMAID:7197 | denotes | liver |
| _T5 | 182-189 | FMAID:256050 | denotes | tissues |
| _T6 | 310-322 | FMAID:196811 | denotes | gangliosides |
| _T7 | 310-322 | FMAID:82816 | denotes | gangliosides |
| _T8 | 426-438 | FMAID:82816 | denotes | gangliosides |
| _T9 | 426-438 | FMAID:196811 | denotes | gangliosides |
| _T10 | 469-481 | FMAID:82816 | denotes | gangliosides |
| _T11 | 469-481 | FMAID:196811 | denotes | gangliosides |
| _T12 | 535-539 | FMAID:198663 | denotes | gene |
| _T13 | 731-742 | FMAID:82816 | denotes | Ganglioside |
| _T14 | 731-742 | FMAID:196811 | denotes | Ganglioside |
| _T15 | 773-778 | FMAID:165448 | denotes | lipid |
| _T16 | 773-778 | FMAID:67264 | denotes | lipid |
| _T17 | 835-840 | FMAID:7197 | denotes | liver |
| _T18 | 835-840 | FMAID:93672 | denotes | liver |
| _T19 | 841-848 | FMAID:256050 | denotes | tissues |
| _T20 | 1026-1038 | FMAID:196811 | denotes | gangliosides |
| _T21 | 1026-1038 | FMAID:82816 | denotes | gangliosides |
| _T22 | 1077-1084 | FMAID:256050 | denotes | tissues |
| _T23 | 1181-1186 | FMAID:93672 | denotes | liver |
| _T24 | 1181-1186 | FMAID:7197 | denotes | liver |
| _T25 | 1187-1194 | FMAID:256050 | denotes | tissues |
| _T26 | 1267-1278 | FMAID:82816 | denotes | ganglioside |
| _T27 | 1267-1278 | FMAID:196811 | denotes | ganglioside |
| _T28 | 1408-1419 | FMAID:196811 | denotes | ganglioside |
| _T29 | 1408-1419 | FMAID:82816 | denotes | ganglioside |
| _T30 | 1481-1488 | FMAID:256050 | denotes | tissues |
| _T31 | 1562-1566 | FMAID:198663 | denotes | gene |
| _T32 | 1694-1701 | FMAID:256050 | denotes | tissues |
| _T33 | 1856-1868 | FMAID:196811 | denotes | gangliosides |
| _T34 | 1856-1868 | FMAID:82816 | denotes | gangliosides |
| _T35 | 1878-1885 | FMAID:256050 | denotes | tissues |
| _T36 | 2069-2080 | FMAID:82816 | denotes | ganglioside |
| _T37 | 2069-2080 | FMAID:196811 | denotes | ganglioside |
| _T38 | 2145-2157 | FMAID:196811 | denotes | gangliosides |
| _T39 | 2145-2157 | FMAID:82816 | denotes | gangliosides |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 106-113 | http://www.uniprot.org/uniprot/P15907 | denotes | ST6GAL1 |
| T2 | 606-613 | http://www.uniprot.org/uniprot/P15907 | denotes | ST6GAL1 |
| T3 | 1636-1643 | http://www.uniprot.org/uniprot/P15907 | denotes | ST6GAL1 |
| T4 | 585-604 | http://www.uniprot.org/uniprot/P15907 | denotes | sialyltransferase 1 |
| T5 | 118-125 | http://www.uniprot.org/uniprot/Q9Y274 | denotes | ST3GAL6 |
| T6 | 660-667 | http://www.uniprot.org/uniprot/Q9Y274 | denotes | ST3GAL6 |
| T7 | 1722-1729 | http://www.uniprot.org/uniprot/Q9Y274 | denotes | ST3GAL6 |
| T8 | 1958-1965 | http://www.uniprot.org/uniprot/Q9Y274 | denotes | ST3GAL6 |
| T9 | 639-658 | http://www.uniprot.org/uniprot/Q8IX54 | denotes | sialyltransferase 6 |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 585-604 | http://www.uniprot.org/uniprot/Q64685 | denotes | sialyltransferase 1 |
| T2 | 639-658 | http://www.uniprot.org/uniprot/P97325 | denotes | sialyltransferase 6 |
| T3 | 1332-1333 | http://www.uniprot.org/uniprot/P10637 | denotes | τ |
| T4 | 1443-1444 | http://www.uniprot.org/uniprot/P10637 | denotes | τ |
| T5 | 1490-1491 | http://www.uniprot.org/uniprot/P10637 | denotes | τ |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 26-29 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
| T2 | 150-160 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinomas |
| T3 | 182-189 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T4 | 451-458 | http://purl.bioontology.org/ontology/NCBITAXON/353209 | denotes | related |
| T5 | 459-462 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
| T6 | 705-714 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T7 | 841-848 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T8 | 932-937 | http://purl.bioontology.org/ontology/NCBITAXON/62990 | denotes | laser |
| T9 | 960-970 | http://purl.bioontology.org/ontology/NCBITAXON/1271577 | denotes | orthogonal |
| T10 | 1016-1019 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
| T11 | 1077-1084 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T12 | 1187-1194 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T13 | 1257-1260 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
| T14 | 1398-1401 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
| T15 | 1481-1488 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T16 | 1658-1667 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancerous |
| T17 | 1694-1701 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T18 | 1846-1849 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
| T19 | 1878-1885 | http://purl.bioontology.org/ontology/STY/T024 | denotes | tissues |
| T20 | 2135-2138 | http://purl.bioontology.org/ontology/NCBITAXON/238707 | denotes | iso |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 535-550 | http://purl.obolibrary.org/obo/GO_0010467 | denotes | gene expression |
| T2 | 1562-1577 | http://purl.obolibrary.org/obo/GO_0010467 | denotes | gene expression |
| T3 | 979-985 | http://purl.obolibrary.org/obo/GO_0060361 | denotes | flight |
| T4 | 1916-1931 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcriptional |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 296-300 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | bind |
| T2 | 296-300 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | bind |
| T3 | 296-300 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | bind |
| T4 | 296-300 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | bind |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 1878-1885 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T1 | 176-181 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T2 | 835-840 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T3 | 1181-1186 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| T4 | 182-189 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T5 | 841-848 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T6 | 1077-1084 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T7 | 1187-1194 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T8 | 1481-1488 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| T9 | 1694-1701 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_21147760_2_0 | 690-714 | expanded | denotes | hepatocellular carcinoma |
| SS2_21147760_2_0 | 716-719 | abbr | denotes | HCC |
| AE1_21147760_2_0 | SS1_21147760_2_0 | SS2_21147760_2_0 | abbreviatedTo | hepatocellular carcinoma,HCC |
EDAM-topics
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 129-134 | http://edamontology.org/topic_2815 | denotes | human |
| T2 | 328-336 | http://edamontology.org/topic_0749 | denotes | terminal |
| T3 | 357-365 | http://edamontology.org/topic_3168 | denotes | sequence |
| T4 | 357-365 | http://edamontology.org/topic_0080 | denotes | sequence |
| T5 | 483-493 | http://edamontology.org/topic_0749 | denotes | terminated |
| T6 | 517-525 | http://edamontology.org/topic_0080 | denotes | sequence |
| T7 | 517-525 | http://edamontology.org/topic_3168 | denotes | sequence |
| T8 | 535-550 | http://edamontology.org/topic_0203 | denotes | gene expression |
| T9 | 773-778 | http://edamontology.org/topic_0153 | denotes | lipid |
| T10 | 986-1003 | http://edamontology.org/topic_0134 | denotes | mass spectrometry |
| T11 | 986-1003 | http://edamontology.org/topic_3520 | denotes | mass spectrometry |
| T12 | 1196-1207 | http://edamontology.org/topic_2269 | denotes | Statistical |
| T13 | 1536-1561 | http://edamontology.org/topic_0195 | denotes | polymerase chain reaction |
| T14 | 1562-1577 | http://edamontology.org/topic_0203 | denotes | gene expression |
| T15 | 1658-1667 | http://edamontology.org/topic_2640 | denotes | cancerous |
| T16 | 1916-1931 | http://edamontology.org/topic_3308 | denotes | transcriptional |
| T17 | 1916-1931 | http://edamontology.org/topic_3512 | denotes | transcriptional |
| T18 | 1916-1931 | http://edamontology.org/topic_0110 | denotes | transcriptional |
| T19 | 1916-1931 | http://edamontology.org/topic_0203 | denotes | transcriptional |
| T20 | 2161-2168 | http://edamontology.org/topic_0154 | denotes | targets |
EDAM-DFO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 357-365 | http://edamontology.org/data_2044 | denotes | sequence |
| T2 | 357-365 | http://edamontology.org/operation_3218 | denotes | sequence |
| T3 | 517-525 | http://edamontology.org/data_2044 | denotes | sequence |
| T4 | 517-525 | http://edamontology.org/operation_3218 | denotes | sequence |
| T5 | 743-753 | http://edamontology.org/data_0883 | denotes | structures |
| T6 | 743-769 | http://edamontology.org/data_3035 | denotes | structures were identified |
| T7 | 759-769 | http://edamontology.org/data_0842 | denotes | identified |
| T8 | 759-769 | http://edamontology.org/data_2611 | denotes | identified |
| T9 | 791-798 | http://edamontology.org/format_1990 | denotes | matched |
| T10 | 799-804 | http://edamontology.org/format_1996 | denotes | pairs |
| T11 | 916-922 | http://edamontology.org/data_2082 | denotes | matrix |
| T12 | 986-1003 | http://edamontology.org/data_3147 | denotes | mass spectrometry |
| T13 | 986-1003 | http://edamontology.org/data_2536 | denotes | mass spectrometry |
| T14 | 1196-1207 | http://edamontology.org/operation_2238 | denotes | Statistical |
| T15 | 1196-1216 | http://edamontology.org/operation_2238 | denotes | Statistical analysis |
| T16 | 1208-1216 | http://edamontology.org/operation_2945 | denotes | analysis |
| T17 | 1228-1239 | http://edamontology.org/operation_3465 | denotes | correlation |
| T18 | 1513-1525 | http://edamontology.org/data_1426 | denotes | Quantitative |
| T19 | 1513-1525 | http://edamontology.org/operation_3630 | denotes | Quantitative |
| T20 | 1562-1586 | http://edamontology.org/operation_2495 | denotes | gene expression analysis |
| T21 | 1562-1586 | http://edamontology.org/operation_0532 | denotes | gene expression analysis |
| T22 | 1562-1586 | http://edamontology.org/operation_3232 | denotes | gene expression analysis |
| T23 | 1562-1586 | http://edamontology.org/operation_2410 | denotes | gene expression analysis |
| T24 | 1562-1586 | http://edamontology.org/operation_3463 | denotes | gene expression analysis |
| T25 | 1578-1586 | http://edamontology.org/operation_2945 | denotes | analysis |
| T26 | 2094-2102 | http://edamontology.org/operation_2428 | denotes | validate |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 21147760-0#106#113#gene6480 | 106-113 | gene6480 | denotes | ST6GAL1 |
| 21147760-0#118#125#gene10402 | 118-125 | gene10402 | denotes | ST3GAL6 |
| 21147760-0#135#160#diseaseC2239176 | 135-160 | diseaseC2239176 | denotes | hepatocellular carcinomas |
| 21147760-2#272#291#gene6487 | 639-658 | gene6487 | denotes | sialyltransferase 6 |
| 21147760-2#323#347#diseaseC2239176 | 690-714 | diseaseC2239176 | denotes | hepatocellular carcinoma |
| 106#113#gene6480135#160#diseaseC2239176 | 21147760-0#106#113#gene6480 | 21147760-0#135#160#diseaseC2239176 | associated_with | ST6GAL1,hepatocellular carcinomas |
| 118#125#gene10402135#160#diseaseC2239176 | 21147760-0#118#125#gene10402 | 21147760-0#135#160#diseaseC2239176 | associated_with | ST3GAL6,hepatocellular carcinomas |
| 272#291#gene6487323#347#diseaseC2239176 | 21147760-2#272#291#gene6487 | 21147760-2#323#347#diseaseC2239176 | associated_with | sialyltransferase 6,hepatocellular carcinoma |
GlycoBiology-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 176-181 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
| T2 | 835-840 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
| T3 | 1181-1186 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-190 | Sentence | denotes | Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. |
| TextSentencer_T2 | 191-366 | Sentence | denotes | The sialic acid-specific cytotoxic lectin viscumin and its recombinant equivalent rViscumin specifically bind to CD75s-gangliosides with terminal Neu5Acα6Galβ4GlcNAc sequence. |
| TextSentencer_T3 | 367-730 | Sentence | denotes | We, therefore, comparatively analyzed the content of CD75s-gangliosides and closely related iso-CD75s-gangliosides (terminated by Neu5Acα3Galβ4GlcNAc sequence) and the gene expression of associated β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) and β-galactoside α-2,3-sialyltransferase 6 (ST3GAL6), respectively, in 35 hepatocellular carcinoma (HCC) patients. |
| TextSentencer_T4 | 731-1004 | Sentence | denotes | Ganglioside structures were identified in lipid extracts of matched pairs of malignant and nonmalignant liver tissues by thin-layer chromatography immunodetection coupled with infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry. |
| TextSentencer_T5 | 1005-1195 | Sentence | denotes | CD75s- and iso-CD75s-gangliosides were found to be deregulated in tumor tissues and showed an elevated occurrence in 35 and 41% of HCCs, respectively, compared with nontumoral liver tissues. |
| TextSentencer_T6 | 1196-1512 | Sentence | denotes | Statistical analysis revealed a correlation between enhanced iso-CD75s-ganglioside amount and a poor histopathological differentiation (τ = 0.317, P = 0.045) and a significant association of CD75s- and iso-CD75s-ganglioside levels in nontumorous (τ = 0.392, P = 0.003) and in tumorous tissues (τ = 0.650, P < 0.001). |
| TextSentencer_T7 | 1513-1702 | Sentence | denotes | Quantitative real-time polymerase chain reaction gene expression analysis of sialyltransferases exhibited no difference in ST6GAL1 expression in cancerous and adjacent noncancerous tissues. |
| TextSentencer_T8 | 1703-1790 | Sentence | denotes | Interestingly, the ST3GAL6 expression was significantly diminished in HCCs (P = 0.003). |
| TextSentencer_T9 | 1791-1980 | Sentence | denotes | The results indicate that the occurrence of CD75s- and iso-CD75s-gangliosides in tumor tissues is largely independent of the transcriptional expression of ST6GAL1 and ST3GAL6, respectively. |
| TextSentencer_T10 | 1981-2198 | Sentence | denotes | Thus, further experiments are required to explore the rationale behind the differential ganglioside level and to validate the applicability of CD75s- and iso-CD75s-gangliosides as targets for individual HCC therapies. |
| T1 | 0-190 | Sentence | denotes | Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. |
| T2 | 191-366 | Sentence | denotes | The sialic acid-specific cytotoxic lectin viscumin and its recombinant equivalent rViscumin specifically bind to CD75s-gangliosides with terminal Neu5Acα6Galβ4GlcNAc sequence. |
| T3 | 367-730 | Sentence | denotes | We, therefore, comparatively analyzed the content of CD75s-gangliosides and closely related iso-CD75s-gangliosides (terminated by Neu5Acα3Galβ4GlcNAc sequence) and the gene expression of associated β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) and β-galactoside α-2,3-sialyltransferase 6 (ST3GAL6), respectively, in 35 hepatocellular carcinoma (HCC) patients. |
| T4 | 731-1004 | Sentence | denotes | Ganglioside structures were identified in lipid extracts of matched pairs of malignant and nonmalignant liver tissues by thin-layer chromatography immunodetection coupled with infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry. |
| T5 | 1005-1195 | Sentence | denotes | CD75s- and iso-CD75s-gangliosides were found to be deregulated in tumor tissues and showed an elevated occurrence in 35 and 41% of HCCs, respectively, compared with nontumoral liver tissues. |
| T6 | 1196-1512 | Sentence | denotes | Statistical analysis revealed a correlation between enhanced iso-CD75s-ganglioside amount and a poor histopathological differentiation (τ = 0.317, P = 0.045) and a significant association of CD75s- and iso-CD75s-ganglioside levels in nontumorous (τ = 0.392, P = 0.003) and in tumorous tissues (τ = 0.650, P < 0.001). |
| T7 | 1513-1702 | Sentence | denotes | Quantitative real-time polymerase chain reaction gene expression analysis of sialyltransferases exhibited no difference in ST6GAL1 expression in cancerous and adjacent noncancerous tissues. |
| T8 | 1703-1790 | Sentence | denotes | Interestingly, the ST3GAL6 expression was significantly diminished in HCCs (P = 0.003). |
| T9 | 1791-1980 | Sentence | denotes | The results indicate that the occurrence of CD75s- and iso-CD75s-gangliosides in tumor tissues is largely independent of the transcriptional expression of ST6GAL1 and ST3GAL6, respectively. |
| T10 | 1981-2198 | Sentence | denotes | Thus, further experiments are required to explore the rationale behind the differential ganglioside level and to validate the applicability of CD75s- and iso-CD75s-gangliosides as targets for individual HCC therapies. |
| T1 | 0-190 | Sentence | denotes | Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. |
| T2 | 191-366 | Sentence | denotes | The sialic acid-specific cytotoxic lectin viscumin and its recombinant equivalent rViscumin specifically bind to CD75s-gangliosides with terminal Neu5Acα6Galβ4GlcNAc sequence. |
| T3 | 367-730 | Sentence | denotes | We, therefore, comparatively analyzed the content of CD75s-gangliosides and closely related iso-CD75s-gangliosides (terminated by Neu5Acα3Galβ4GlcNAc sequence) and the gene expression of associated β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) and β-galactoside α-2,3-sialyltransferase 6 (ST3GAL6), respectively, in 35 hepatocellular carcinoma (HCC) patients. |
| T4 | 731-1004 | Sentence | denotes | Ganglioside structures were identified in lipid extracts of matched pairs of malignant and nonmalignant liver tissues by thin-layer chromatography immunodetection coupled with infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry. |
| T5 | 1005-1195 | Sentence | denotes | CD75s- and iso-CD75s-gangliosides were found to be deregulated in tumor tissues and showed an elevated occurrence in 35 and 41% of HCCs, respectively, compared with nontumoral liver tissues. |
| T6 | 1196-1512 | Sentence | denotes | Statistical analysis revealed a correlation between enhanced iso-CD75s-ganglioside amount and a poor histopathological differentiation (τ = 0.317, P = 0.045) and a significant association of CD75s- and iso-CD75s-ganglioside levels in nontumorous (τ = 0.392, P = 0.003) and in tumorous tissues (τ = 0.650, P < 0.001). |
| T7 | 1513-1702 | Sentence | denotes | Quantitative real-time polymerase chain reaction gene expression analysis of sialyltransferases exhibited no difference in ST6GAL1 expression in cancerous and adjacent noncancerous tissues. |
| T8 | 1703-1790 | Sentence | denotes | Interestingly, the ST3GAL6 expression was significantly diminished in HCCs (P = 0.003). |
| T9 | 1791-1980 | Sentence | denotes | The results indicate that the occurrence of CD75s- and iso-CD75s-gangliosides in tumor tissues is largely independent of the transcriptional expression of ST6GAL1 and ST3GAL6, respectively. |
| T10 | 1981-2198 | Sentence | denotes | Thus, further experiments are required to explore the rationale behind the differential ganglioside level and to validate the applicability of CD75s- and iso-CD75s-gangliosides as targets for individual HCC therapies. |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 176-181 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| PD-UBERON-AE-B_T2 | 835-840 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| PD-UBERON-AE-B_T3 | 1181-1186 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
| PD-UBERON-AE-B_T4 | 182-189 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T5 | 841-848 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T6 | 1077-1084 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T7 | 1187-1194 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T8 | 1481-1488 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T9 | 1694-1701 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
| PD-UBERON-AE-B_T10 | 1878-1885 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 337-343 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T2 | 497-503 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 135-160 | Disease | denotes | hepatocellular carcinomas | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T2 | 690-714 | Disease | denotes | hepatocellular carcinoma | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T3 | 716-719 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
| T4 | 1071-1076 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T5 | 1872-1877 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T6 | 2184-2187 | Disease | denotes | HCC | http://purl.obolibrary.org/obo/MONDO_0007256 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 176-181 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
| T2 | 835-840 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
| T3 | 1181-1186 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 135-160 | Phenotype | denotes | hepatocellular carcinomas | HP:0001402 |
| T2 | 690-714 | Phenotype | denotes | hepatocellular carcinoma | HP:0001402 |
| T3 | 716-719 | Phenotype | denotes | HCC | HP:0001402 |
| T4 | 1071-1076 | Phenotype | denotes | tumor | HP:0002664 |
| T5 | 1872-1877 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 2184-2187 | Phenotype | denotes | HCC | HP:0001402 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 135-160 | Phenotype | denotes | hepatocellular carcinomas | HP:0001402 |
| T2 | 690-714 | Phenotype | denotes | hepatocellular carcinoma | HP:0001402 |
| T3 | 716-719 | Phenotype | denotes | HCC | HP:0001402 |
| T4 | 1071-1076 | Phenotype | denotes | tumor | HP:0002664 |
| T5 | 1872-1877 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 2184-2187 | Phenotype | denotes | HCC | HP:0001402 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 176-181 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T2 | 835-840 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T3 | 1181-1186 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 135-160 | Disease | denotes | hepatocellular carcinomas | MONDO:0007256 |
| T2 | 690-714 | Disease | denotes | hepatocellular carcinoma | MONDO:0007256 |
| T3 | 716-719 | Disease | denotes | HCC | MONDO:0007256 |
| T4 | 1071-1076 | Disease | denotes | tumor | MONDO:0005070 |
| T5 | 1872-1877 | Disease | denotes | tumor | MONDO:0005070 |
| T6 | 2184-2187 | Disease | denotes | HCC | MONDO:0007256 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 129-134 | Organism | denotes | human | 9606 |
| T2 | 721-729 | Organism | denotes | patients | 9606 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-190 | Sentence | denotes | Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. |
| T2 | 191-366 | Sentence | denotes | The sialic acid-specific cytotoxic lectin viscumin and its recombinant equivalent rViscumin specifically bind to CD75s-gangliosides with terminal Neu5Acα6Galβ4GlcNAc sequence. |
| T3 | 367-730 | Sentence | denotes | We, therefore, comparatively analyzed the content of CD75s-gangliosides and closely related iso-CD75s-gangliosides (terminated by Neu5Acα3Galβ4GlcNAc sequence) and the gene expression of associated β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) and β-galactoside α-2,3-sialyltransferase 6 (ST3GAL6), respectively, in 35 hepatocellular carcinoma (HCC) patients. |
| T4 | 731-1004 | Sentence | denotes | Ganglioside structures were identified in lipid extracts of matched pairs of malignant and nonmalignant liver tissues by thin-layer chromatography immunodetection coupled with infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry. |
| T5 | 1005-1195 | Sentence | denotes | CD75s- and iso-CD75s-gangliosides were found to be deregulated in tumor tissues and showed an elevated occurrence in 35 and 41% of HCCs, respectively, compared with nontumoral liver tissues. |
| T6 | 1196-1512 | Sentence | denotes | Statistical analysis revealed a correlation between enhanced iso-CD75s-ganglioside amount and a poor histopathological differentiation (τ = 0.317, P = 0.045) and a significant association of CD75s- and iso-CD75s-ganglioside levels in nontumorous (τ = 0.392, P = 0.003) and in tumorous tissues (τ = 0.650, P < 0.001). |
| T7 | 1513-1702 | Sentence | denotes | Quantitative real-time polymerase chain reaction gene expression analysis of sialyltransferases exhibited no difference in ST6GAL1 expression in cancerous and adjacent noncancerous tissues. |
| T8 | 1703-1790 | Sentence | denotes | Interestingly, the ST3GAL6 expression was significantly diminished in HCCs (P = 0.003). |
| T9 | 1791-1980 | Sentence | denotes | The results indicate that the occurrence of CD75s- and iso-CD75s-gangliosides in tumor tissues is largely independent of the transcriptional expression of ST6GAL1 and ST3GAL6, respectively. |
| T10 | 1981-2198 | Sentence | denotes | Thus, further experiments are required to explore the rationale behind the differential ganglioside level and to validate the applicability of CD75s- and iso-CD75s-gangliosides as targets for individual HCC therapies. |
Lectin-Jamboree-Sentence
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-190 | Sentence | denotes | Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. |
| T2 | 191-366 | Sentence | denotes | The sialic acid-specific cytotoxic lectin viscumin and its recombinant equivalent rViscumin specifically bind to CD75s-gangliosides with terminal Neu5Acα6Galβ4GlcNAc sequence. |
| T3 | 367-730 | Sentence | denotes | We, therefore, comparatively analyzed the content of CD75s-gangliosides and closely related iso-CD75s-gangliosides (terminated by Neu5Acα3Galβ4GlcNAc sequence) and the gene expression of associated β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) and β-galactoside α-2,3-sialyltransferase 6 (ST3GAL6), respectively, in 35 hepatocellular carcinoma (HCC) patients. |
| T4 | 731-1004 | Sentence | denotes | Ganglioside structures were identified in lipid extracts of matched pairs of malignant and nonmalignant liver tissues by thin-layer chromatography immunodetection coupled with infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry. |
| T5 | 1005-1195 | Sentence | denotes | CD75s- and iso-CD75s-gangliosides were found to be deregulated in tumor tissues and showed an elevated occurrence in 35 and 41% of HCCs, respectively, compared with nontumoral liver tissues. |
| T6 | 1196-1512 | Sentence | denotes | Statistical analysis revealed a correlation between enhanced iso-CD75s-ganglioside amount and a poor histopathological differentiation (τ = 0.317, P = 0.045) and a significant association of CD75s- and iso-CD75s-ganglioside levels in nontumorous (τ = 0.392, P = 0.003) and in tumorous tissues (τ = 0.650, P < 0.001). |
| T7 | 1513-1702 | Sentence | denotes | Quantitative real-time polymerase chain reaction gene expression analysis of sialyltransferases exhibited no difference in ST6GAL1 expression in cancerous and adjacent noncancerous tissues. |
| T8 | 1703-1790 | Sentence | denotes | Interestingly, the ST3GAL6 expression was significantly diminished in HCCs (P = 0.003). |
| T9 | 1791-1980 | Sentence | denotes | The results indicate that the occurrence of CD75s- and iso-CD75s-gangliosides in tumor tissues is largely independent of the transcriptional expression of ST6GAL1 and ST3GAL6, respectively. |
| T10 | 1981-2198 | Sentence | denotes | Thus, further experiments are required to explore the rationale behind the differential ganglioside level and to validate the applicability of CD75s- and iso-CD75s-gangliosides as targets for individual HCC therapies. |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 176-181 | Body_part | denotes | liver | FMA:7197 |
| T2 | 182-189 | Body_part | denotes | tissues | FMA:9637 |
| T3 | 835-840 | Body_part | denotes | liver | FMA:7197 |
| T4 | 841-848 | Body_part | denotes | tissues | FMA:9637 |
| T5 | 1077-1084 | Body_part | denotes | tissues | FMA:9637 |
| T6 | 1181-1186 | Body_part | denotes | liver | FMA:7197 |
| T7 | 1187-1194 | Body_part | denotes | tissues | FMA:9637 |
| T8 | 1481-1488 | Body_part | denotes | tissues | FMA:9637 |
| T9 | 1694-1701 | Body_part | denotes | tissues | FMA:9637 |
| T10 | 1878-1885 | Body_part | denotes | tissues | FMA:9637 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 176-181 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
| T2 | 835-840 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
| T3 | 1181-1186 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 129-134 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 176-181 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T2 | 835-840 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T3 | 857-862 | Body_part | denotes | layer | http://purl.obolibrary.org/obo/UBERON_0000119|http://purl.obolibrary.org/obo/UBERON_0022303 |
| T5 | 1181-1186 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |